The FDA Modernization Act 2.0: The End of IND-Enabling Toxicology Studies?
The Premier Consulting Blog
APRIL 25, 2023
As a result, the FDA is now required to consider alternatives to animal testing, such as in vitro , in silico , and in chemico tests and models. In this blog post, we examine several alternative approaches to animal testing and how the FDA handles the application of these methods in specific scenarios.
52 
Let's personalize your content